EPO Patent Publication: PTK7-Binding Protein
Summary
The European Patent Office has published a patent application (EP4573129A1) for a PTK7-binding protein and its use, filed by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. The publication date is March 18, 2026.
What changed
This document is a publication of a European patent application (EP4573129A1) by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., concerning a PTK7-binding protein and its therapeutic uses, particularly in treating cancer. The publication date is March 18, 2026.
As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property rights and may influence research and development strategies within the pharmaceutical and biotechnology sectors.
Source document (simplified)
PTK7-BINDING PROTEIN AND USE THEREOF
Publication EP4573129A1 Kind: A1 Mar 18, 2026
Applicants
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Inventors
LONG, Hu, HU, Jiangjiang, CHEN, Mei, LIU, Hanjie, JIANG, Hongjiao, GE, Junyou, TAN, Xiangyang, TAN, Miao
IPC Classifications
C07K 16/30 20060101AFI20240223BHEP C07K 16/40 20060101ALI20240223BHEP A61P 35/00 20060101ALI20240223BHEP A61K 39/395 20060101ALI20240223BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.